Cargando…
Inhibitory effect of novel Eugenol Tosylate Congeners on pathogenicity of Candida albicans
BACKGROUND: The global prevalence of fungal diseases is increasing rapidly, which affects more than a billion people every year with significant mortality rate. On the other hand, the development of new drugs to treat these fungal infections is slow, while the current antifungal therapy is insuffici...
Autores principales: | Lone, Shabir Ahmad, Ahmad, Aijaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7191809/ https://www.ncbi.nlm.nih.gov/pubmed/32349730 http://dx.doi.org/10.1186/s12906-020-02929-0 |
Ejemplares similares
-
Cellular apoptosis and necrosis as therapeutic targets for novel Eugenol Tosylate Congeners against Candida albicans
por: Lone, Shabir Ahmad, et al.
Publicado: (2020) -
Synergistic Interactions of Eugenol-tosylate and Its Congeners with Fluconazole against Candida albicans
por: Ahmad, Aijaz, et al.
Publicado: (2015) -
Antifungal effects of eugenol on Candida albicans adherence to denture polymers
por: Zanul Abidin, Zubaidah, et al.
Publicado: (2023) -
Beta vulgaris Assisted Fabrication of Novel Ag-Cu Bimetallic Nanoparticles for Growth Inhibition and Virulence in Candida albicans
por: Kamli, Majid Rasool, et al.
Publicado: (2021) -
Synergistic interaction of eugenol and antimicrobial drugs in eradication of single and mixed biofilms of Candida albicans and Streptococcus mutans
por: Jafri, Huma, et al.
Publicado: (2020)